| Bortezomib for treatment of therapy-refractory anti-NMDA receptor encephalitis F Scheibe, H Prüss, AM Mengel, S Kohler, A Nümann, M Köhnlein, ... Neurology 88 (4), 366-370, 2017 | 196 | 2017 |
| COVID‐19 vaccine‐associated cerebral venous thrombosis in Germany JB Schulz, P Berlit, HC Diener, C Gerloff, A Greinacher, C Klein, ... Annals of neurology 90 (4), 627-639, 2021 | 169 | 2021 |
| Characteristics and outcomes of patients with cerebral venous sinus thrombosis in SARS-CoV-2 vaccine–induced immune thrombotic thrombocytopenia MS Van Kammen, DA De Sousa, S Poli, C Cordonnier, MR Heldner, ... JAMA neurology 78 (11), 1314-1323, 2021 | 112 | 2021 |
| Systematic evaluation of stroke thrombectomy in clinical practice: The German Stroke Registry Endovascular Treatment AC Alegiani, F Dorn, M Herzberg, FA Wollenweber, L Kellert, E Siebert, ... International Journal of Stroke 14 (4), 372-380, 2019 | 99 | 2019 |
| Effects of escitalopram on the regulation of brain‐derived neurotrophic factor and nerve growth factor protein levels in a rat model of chronic stress O Schulte‐Herbrüggen, E Fuchs, N Abumaria, A Ziegler, H Danker‐Hopfe, ... Journal of neuroscience research 87 (11), 2551-2560, 2009 | 67 | 2009 |
| Intravenous thrombolysis in patients with ischemic stroke and recent ingestion of direct oral anticoagulants TR Meinel, D Wilson, H Gensicke, JF Scheitz, P Ringleb, I Goganau, ... JAMA neurology 80 (3), 233-243, 2023 | 62 | 2023 |
| Cardiac myxoma and cerebrovascular events: a retrospective cohort study MI Stefanou, D Rath, V Stadler, H Richter, F Hennersdorf, HF Lausberg, ... Frontiers in neurology 9, 823, 2018 | 59 | 2018 |
| Severe renal impairment is associated with symptomatic intracerebral hemorrhage after thrombolysis for ischemic stroke S Tütüncü, AM Ziegler, JF Scheitz, T Slowinski, A Rocco, M Endres, ... Stroke 44 (11), 3217-3219, 2013 | 54 | 2013 |
| The use of IV immunoglobulin in the treatment of vaccine-induced immune thrombotic thrombocytopenia G Uzun, K Althaus, A Singh, P Möller, U Ziemann, A Mengel, ... Blood, The Journal of the American Society of Hematology 138 (11), 992-996, 2021 | 45 | 2021 |
| Secondary prevention after minor stroke and TIA-usual care and development of a support program S Leistner, S Benik, I Laumeier, A Ziegler, G Nieweler, CH Nolte, ... PloS one 7 (12), e49985, 2012 | 44 | 2012 |
| Anti-Ca/anti-ARHGAP26 antibodies associated with cerebellar atrophy and cognitive decline S Doss, A Nümann, A Ziegler, E Siebert, K Borowski, W Stöcker, H Prüss, ... Journal of neuroimmunology 267 (1-2), 102-104, 2014 | 43 | 2014 |
| Glucocorticoids in myasthenia gravis–if, when, how, and how much? S Hoffmann, S Kohler, A Ziegler, A Meisel Acta Neurologica Scandinavica 130 (4), 211-221, 2014 | 41 | 2014 |
| Biomarkers of immune capacity, infection and inflammation are associated with poor outcome and mortality after stroke-the PREDICT study A Mengel, L Ulm, B Hotter, H Harms, SK Piper, U Grittner, J Montaner, ... BMC neurology 19, 1-10, 2019 | 40 | 2019 |
| Early administration of desmopressin and platelet transfusion for reducing hematoma expansion in patients with acute antiplatelet therapy associated intracerebral hemorrhage A Mengel, MI Stefanou, KA Hadaschik, M Wolf, V Stadler, K Poli, T Lindig, ... Critical Care Medicine 48 (7), 1009-1017, 2020 | 36 | 2020 |
| Judgment of FLAIR signal change in DWI–FLAIR mismatch determination is a challenge to clinicians A Ziegler, M Ebinger, JB Fiebach, HJ Audebert, S Leistner Journal of neurology 259, 971-973, 2012 | 32 | 2012 |
| Hepatitis E–induced severe myositis AM Mengel, W Stenzel, A Meisel, C Büning Muscle & Nerve 53 (2), 317-320, 2016 | 31 | 2016 |
| Anti-NMDAR encephalitis mimicking HaNDL syndrome C Finke, A Mengel, H Prüss, W Stöcker, A Meisel, K Ruprecht Cephalalgia 34 (12), 1012-1014, 2014 | 29 | 2014 |
| Course and recognition of poststroke delirium: a prospective noninferiority trial of delirium screening tools R Fleischmann, S Warwas, T Andrasch, R Kunz, C Witt, A Mengel, ... Stroke 52 (2), 471-478, 2021 | 27 | 2021 |
| Recurrent ischaemic cerebrovascular events as presenting manifestations of myeloproliferative neoplasms MI Stefanou, H Richter, F Härtig, Y Wang, A Örgel, B Bender, A Mengel, ... European journal of neurology 26 (6), 903-e64, 2019 | 27 | 2019 |
| Diagnostic and therapeutic approach to autoimmune neurologic disorders AS López-Chiriboga, EP Flanagan Seminars in Neurology 38 (03), 392-402, 2018 | 27 | 2018 |
